Biotech rally mints huge profits for hedge funds

Healthcare-focused hedge funds have achieved significant performance amid a surge in biotech M&A activity. And as PivotalPath shared with the Financial Times, understanding the true strength of this performance requires a full understanding of the complete healthcare fund peer group.

The PivotalPath Equity Sector Healthcare Index returned 36% through November, marking its strongest year since 2013, with nearly half of those gains concentrated in the past two months. As Jon Caplis notes, the numbers here are staggering.